AtriCure, Inc. — Director's Dealing 2020

Jan 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-01-16

Reporting Person: Wade M. Andrew (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-16	Common Stock	M	10000	$6.27	Acquired	155120	Direct
2020-01-16	Common Stock	S	10000	$36.00	Disposed	145120	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-16	Stock Option (Right to Buy)	$6.27	M	10000	Disposed	2022-10-25	Common Stock (10000)	Direct

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: These options were granted on October 25, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.